3 / 6
Volume 9
Journal of Allergy & Therapy
ISSN: 2155-6121
Allergy-Clinical Immunology 2018
October 01-02, 2018
Notes:
conference
series
.com
Page 7
October 01-02, 2018 | Moscow, Russia
12
th
International Conference on
Allergy, Asthma & Clinical Immunology
Glady Gilbert, J Allergy Ther 2018, Volume 9
DOI: 10.4172/2155-6121-C2-008
A sublingual immuno-nanotherapy related to the pathophysiological mechanisms of asthma
F
or a very long time, it has been customary in medicine to treat diseases by opposing the effects of certain cells or molecules
whose disruption is directly involved in the evolutionary course of a disease. The therapeutic results have not always been up to
expectations, and the deleterious effects on the other hand often beyond expectations. Besides, these often disappointing results have
resulted from very expensive investments. Allergic asthma is one of these diseases, where progress in terms of treatment is not up to
the hopes raised by the many basic research works published in recent years and illuminating many physiopathological mechanisms
very accurately. The fault probably lies in the absence of a global vision to address the disease at multiple levels of dysfunction at the
same time, with the aim to implement a multifocal regulation based on the main pathogenic mechanisms at the origin of asthma. We
have developed in recent years a nanotherapy method called Bio Immune(G)ene Medicine (BI(G)MED), allowing a fine regulation
of this type of allergic diseases by using first and foremost a biomimetic and holistic approach, devoid of any additional adverse
effects.
Biography
Glady Gilbert has graduated Medical School in 1977. Through his work and encounters, he then developed interest and expertise in immunology and immunogenetics
that lead him to nanomedicine and nanobiotechnology. He thus became in 2010 the creator of the Bio Immune(G)ene Medicine and Director of EBMA, the European
association responsible for communication and trainings in this field. He has participated in numerous international congresses in immuno-allergology, infectiology and
oncology and is the author of several publications on nano-biotherapy in different journals.
info@ebma-europe.comGlady Gilbert
European Bio Immune(G)ene Medicine Association, France